Search Medical Condition
Please enter condition
Please choose location

Broomfield, Colorado Clinical Trials

A listing of Broomfield, Colorado clinical trials actively recruiting patient volunteers.

RESULTS

Found (41) clinical trials

Regenexx SD Versus Exercise Therapy for Rotator Cuff Tears

Prospective, randomized, controlled to include 25 subjects treated with Regenexx SD and 25 subjects treated with Exercise Therapy alone. Subjects will have a non-retracted supraspinatus tendon tear comprising at least one half the tendon thickness in the anterior-posterior and/or superior-inferior planes as evidenced with positive diagnostic imaging such as arthrogram, ...

Phase N/A

2.83 miles

Learn More »

Regenexx SD Versus Exercise Therapy for ACL Tears

Prospective, randomized, controlled to include 25 subjects treated with Regenexx SD and 25 subjects treated with exercise therapy alone with the exercise group crossing over to the injection group at 3 months. Subjects will have a partial or complete, non-retracted ACL ligament tear as evidenced with MRI. Subjects will be ...

Phase N/A

2.83 miles

Learn More »

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With Metformin

The duration per patient is up to 85 weeks, including a Screening Period consisting of a Screening phase of up to 2 weeks and a 2-week single-blind Run-in phase, a 26-week double blind Core Treatment Period, a 53 week double blind Extension, and a 2-week post treatment Follow-up period to ...

Phase

4.07 miles

Learn More »

Evaluation of Moderate to Severe Influenza Outcomes in Children

This prospective observational study aims to determine the risk difference of hospitalization due to moderate to severe influenza compared with mild influenza among children aged 6 months to 8 years who are evaluated at Children's Hospital Colorado emergency department and urgent care during the 2016-2017 influenza season. In addition, it ...

Phase N/A

4.76 miles

Learn More »

Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer.

Patients will be randomised in 1:1 ratio to either olaparib or placebo. Randomisation will be stratified by Hormone receptor status (ER and/or PgR positive/HER2 negative versus TNBC), prior neoadjuvant versus adjuvant chemotherapy and prior platinum use for breast cancer. Randomised patients will receive study treatment for up to a maximum ...

Phase

5.38 miles

Learn More »